Causalus (private company)

See something wrong or missing? Let us know
Offices:
Helsinki
Business model:
B2B
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Causalus, developed by Pharmanalysis Oy, a software solution solving the challenges related to polypharmacy used for senior patients. The software service comprises of cloud-based software and remote pharmacist service and reviews and monitors medication and its impact.

Companies with similar profile to Causalus:

CompanyCriteria
Finland FinnAdvance
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Icebreaker
Finland Cerenion
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Icebreaker
  • Total raised in a similar range: < 1M USD
Finland MVision AI
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Icebreaker
  • Total raised in a similar range: < 1M USD
Finland Osgenic
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Icebreaker
  • Total raised in a similar range: < 1M USD
Finland Valpas
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Icebreaker
  • Total raised in a similar range: < 1M USD
Iceland geoSilica
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Finland Montisera
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Iceland EpiEndo Pharmaceuticals
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Denmark Particle 3D
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden PeptiSystems
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Gnosco
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden Merozyne Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Iceland 3Z Pharmaceuticals
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Sweden AttgeNO
34%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden Athera
34%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Sweden Saga Diagnostics
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Norway Cytovation
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Quretech Bio
34%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
Finland RoadCloud
34%
  • Similar business models: B2B
  • At least one vc investor: Icebreaker
  • Total raised in a similar range: < 1M USD
Norway Vaccibody
34%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B